BUILDING YOUR RELATIONSHIP WITH INVESTORS
Consilium Global Research (CGR) is the bridge between companies and investors. To improve our clients' market valuation, increase trading activity and lower cost of capital, we provide a thorough and objective company analysis, distributed throughout the institutional and retail investment communities, one-on-one meetings with targeted investors, and relevant advisory services.

READ MORE

Sample Research Reports

Neah Power Systems
Neah Power Systems  |  OTCQB:NPWZ

Neah Power Systems, Inc. is a developer of innovative, long-lasting, efficient and safe power solutions for the military, transportation, and portable electronics applications.

Sino Agro Food
Sino Agro Food  |  SIAF: OTCQB

Sino Agro Food, Inc. (SIAF) is an integrated developer, producer and distributor of organic food and agricultural products in the Peoples Republic of China (PRC).

Orbital Corp. LTD.
ORBITAL CORP. LTD.  |  AMEX: OBT, ASX: OEC

Orbital Corp. is a leading designer and manufacturer of fuel injection components and engine management systems for both gasoline and alternative fuel systems. Orbital has introduced next-generation LPG “Liquid” fuel injection technology (LPi; liquid phase injection) which offers enhanced performance compared to previous generation LPG systems.


VIRALYTICS  |   OTCPK: VRACY, ASX: VRX

Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market (VRACY). Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers, Viralytics’ headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia.

iSONEA
iSONEA   |  ASX: ISN

iSonea Ltd. (formally KarmelSonix) engages in the development, manufacture, and sale of asthma monitoring products. The company sells its products through independent third-party distributors and strategic alliances.


NEOGENIX  |  PRIVATE

Neogenix is a biotechnology research company that has engineered specific monoclonal antibodies that in laboratory tests have generated exceptional results in limiting and even eliminating human cancer tumors in mice. Successful clinical trials (the company is in Phase I trials with its antibody NEO-101; Ensituximab [formerly known as NPC-1C]) could greatly impact cancer treatment as we know it today.



 
 

Consilium (Latin) /koːn'si.li.um/ v,   1. Plan: a specific project or definite purpose